IGFBP3 and neuronal ceroid lipofuscinosis: In summary, we have studied the biodistribution and pharmacokinetics of human IGF-1 administrated free or complexed to its natural binding protein IGFBP-3 or nanoparticles in infantile neuronal ceroid lipofuscinosis (INCL) mouse model.